CONSIDERATIONS FOR FORMULATING THE 2ND-GENERATION PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE WITH EMPHASIS ON THE CROSS-REACTIVE TYPES WITHIN GROUPS

被引:501
作者
ROBBINS, JB
AUSTRIAN, R
LEE, CJ
RASTOGI, SC
SCHIFFMAN, G
HENRICHSEN, J
MAKELA, PH
BROOME, CV
FACKLAM, RR
TIESJEMA, RH
PARKE, JC
机构
[1] US FDA, BIOL OFF, BETHESDA, MD USA
[2] UNIV PENN, SCH MED, DEPT RES MED, PHILADELPHIA, PA 19104 USA
[3] SUNY DOWNSTATE MED CTR, DEPT MICROBIOL, BROOKLYN, NY 11203 USA
[4] WHO, COLLABORATING CTR REFERENCE & RES PNEUMOCOCCI, STATENS SERUMINST, COPENHAGEN, DENMARK
[5] STATE SERUM INST, CENT PUBL HLTH LAB, HELSINKI, FINLAND
[6] CTR DIS CONTROL, RESP & SPECIAL PATHOGENS BRANCH, ATLANTA, GA 30333 USA
[7] RIJKSINST VOLKSGEZONDHEID, BILTHOVEN, NETHERLANDS
[8] CHARLOTTE MEM HOSP, DEPT PEDIAT, CHARLOTTE, NC USA
关键词
D O I
10.1093/infdis/148.6.1136
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1136 / 1159
页数:24
相关论文
共 171 条